Diego Villa

机构：BC Cancer Agency, University of British Columbia, Spinal Cord Injury BC, Canadian Centre for Applied Research in Cancer Control · ORCID：0000-0002-4625-3009

发表论文 350 篇 · 总被引 7707 次 · h-index 47

代表论文

• Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study (2025 · Blood · 被引 10)
• Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma (2025 · Blood Advances · 被引 7)
• Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up (2025 · Blood · 被引 5)
• Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC / BCL2 rearrangements, DLBCL morphology (2025 · Blood Advances · 被引 4)
• High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis (2026 · Journal of Clinical Oncology · 被引 1)
• FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma (2025 · Journal of Clinical Oncology · 被引 1)